Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Cell & Gene Therapy Asia 2019

Cell & Gene Therapy Asia 2019

Date: Monday, 11 November 2019 - Tuesday, 12 November 2019
Location: Kobe, Japan


Conference Chair

Norio Nakatsuji

Norio Nakatsuji
Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University

Keynote Speakers

Kinichi Nakashima

Kinichi Nakashima
Professor, Department of Stem Cell Biology and Medicine, Kyushu University

Takahiro Ochiya

Takahiro Ochiya
Professor, Tokyo Medical University

Masafumi Onodera

Masafumi Onodera
Head, Department of Human Genetics, National Center for Child Health and Development

Yuji Shiba

Yuji Shiba
Professor, Department of Regenerative Science and Medicine, Shinshu University

Noboru Yamaji

Noboru Yamaji
President, Chief Intelligence and Liaison Officer, Universal Cells, Inc., An Astellas Company

Keiya Ozawa

Keiya Ozawa
Professor Emeritus and Visiting Professor of the Division of Immuno-Gene & Cell Therapy, Jichi Medical University

Shoji Takeuchi

Shoji Takeuchi
Professor, Center For International Research on Integrative Biomedical Systems (CIBiS), Institute of Industrial Science, The University of Tokyo

Ross  Macdonald

Ross Macdonald
Chief Executive Officer and Managing Director, Cynata Therapeutics Ltd

Chae-Ok Yun

Chae-Ok Yun
Professor, Department of Bioengineering, Hanyang University

Hiroshi Kawamoto

Hiroshi Kawamoto
Professor, Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University

Overview

SelectBIO is pleased to welcome you to the Second Annual Cell & Gene Therapy Asia 2019 which will be held in Kobe, Japan on November 11-12, 2019.

This conference brings together academic and industry participants focusing on many aspects of this rapidly expanding and evolving field including stem cells for cellular therapy, iPSCs and their deployment for research, pharmaceutical discovery and cellular therapy, immuno-oncology (IO) including CAR-T cell research and clinical application and technologies for gene therapy.

The conference addresses the whole ecosystem of Cell & Gene Therapy and 3D-Bioprinting with a focus on 3D-Culture, Organoids, Bioprinting and Technology Platforms being developed to bring cell therapy, gene therapy and regenerative medicine to the clinic.

In addition to presentations from academics, the program includes an emphasis on presentations from companies as well as posters to illustrate late-breaking research and an exhibit hall with companies seeking to engage with delegates from Europe, US, across Asia/Pacific and Japan.

With its strong biomedical research infrastructure, Kobe Japan is a perfect venue for Cell & Gene Therapy Asia 2019.

SelectBIO is honored that Professor Norio Nakatsuji, Professor Emeritus Kyoto University will be leading the conference as Chairman and invites young scientists to submit poster abstracts to the conference and participate in the conference.

Information and Local Registration Facilities for this Conference are Also Available In:

Japanese  |  Korean  |  Chinese (Simplified)  |  Chinese (Traditional)

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 31 October 2019

Agenda Topics

  • 3D-Bioprinting and Tissue Engineering
  • 3D-Culture and Organoids
  • Clinical Trials and Commercialization of Cell Therapies
  • Gene Therapy into the Clinic
    • Clinical Pipeline
    • Regulatory Landscape
    • Technology Platforms
  • iPSC-derived Cells for Toxicity Testing, Screening and Cellular Therapy
  • Mesenchymal Stem Cells (MSCs): Their Potential for Cellular Therapy
  • Regenerative Medicine
  • Stem Cells for Cellular Therapy

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Ryan Chang, CEO, Steminent Biotherapeutics
Toshiyoshi Fujiwara, Professor & Chairman, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Yasufumi Kaneda, Professor, Osaka University
Thai-Yen Ling, Associate Professor, National Taiwan University
Eugen Molodysky, Clinical Associate Professor, Sydney Medical School, University of Sydney
Ryuichi Morishita, Professor of Clinical Gene Therapy, Osaka University School of Medicine
Asuka Morizane, Assistant Professor, Center for iPS Cell Research and Application (CiRA), Kyoto University
Shin-ichi Muramatsu , Professor of Neurology, Jichi Medical University (JMU)
Toshihiro Nakajima, Senior Technical Executive and General Manager of Manufacturing, GenomIdea, Inc.
Yasutomo Nasu, Professor, Okayama University
Kennedy Okeyo, Senior Lecturer, Institute for Frontier Life and Medical Sciences, Kyoto University
Ricky Solorzano, CEO, Allevi
Jun Takahashi, Professor, Kyoto University
William G Whitford, Strategic Solutions Leader Bioprocess, GE Healthcare Life Sciences
Yoshikazu Yonemitsu, Professor, Kyushu University Graduate School of Pharmaceutical Sciences


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2019-11-11 00:00:002019-11-12 00:00:00Europe/LondonCell and Gene Therapy Asia 2019Cell and Gene Therapy Asia 2019 in Kobe, JapanKobe, JapanSELECTBIOenquiries@selectbiosciences.com